• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Automatic Data Processing, Inc.

Automatic Data Processing, Inc.

Automatic Data Processing ADP 2 Star

Last Price$84.14Day Change (%)0.03%
Open Price$84.96Day Change ($)0.02
Day Range83.81–85.2252-Week Range63.08–85.89

As of Fri 11/21/2014 05:13 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Dollar Pushes to New High Against Yen on U.S. Economic Hopes

    Dollar Pushes to New High Against Yen on U.S. Economic Hopes

  2. U.S. Stocks Rise After Midterm Elections

    U.S. Stocks Rise After Midterm Elections

  3. 5 'dividend aristocrat' stocks set to boost earnings up to 77%

    5 'dividend aristocrat' stocks set to boost earnings up to 77%

  4. Our Ultimate Stock-Pickers' Top 10 Buys and Sells

    The ongoing rally in the equity markets continues to limit the buying and selling activity of our top managers.

  5. Staffing Industry and Executive Search Guru Lisa Maxwell Offers Tips for Hiring the Best Senior Leaders Given the Convergence of Staffing and Consulting

    Staffing Industry and Executive Search Guru Lisa Maxwell Offers Tips for Hiring the Best Senior Leaders Given the Convergence of Staffing and Consulting

  6. Zugzwang, the 40-week cycle and how the Fed is robbing retirees

    Zugzwang, the 40-week cycle and how the Fed is robbing retirees

  7. ADP Supports Applicants Reentering the Workforce with New Additions to the ADP SmartCompliance® Unemployment Claims Module

    ADP Supports Applicants Reentering the Workforce with New Additions to the ADP SmartCompliance® Unemployment Claims Module

  8. ADP Webcast--What Small Businesses Need to Know About the ACA: Actions You May Need to Take Before Year End

    ADP Webcast--What Small Businesses Need to Know About the ACA: Actions You May Need to Take Before Year End

  9. Foundation Medicine’s Novel Companion Diagnostic Test, Developed in Collaboration with Clovis Oncology, Identifies Expanded Subgroup of Cancer Patients with the Potential to Respond to Clovis ...

    Foundation Medicine’s Novel Companion Diagnostic Test, Developed in Collaboration with Clovis Oncology, Identifies Expanded Subgroup of Cancer Patients with the Potential to Respond to Clovis Oncology’s PARP inhibitor, Rucaparib

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.